Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate
Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate
此外，Therapeutics第四季度每股收益美元（0.70美元）超過預期（1.07美元），銷售額131萬美元超過106萬美元的預期
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.07) by 34.58 percent. This is a 70.83 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $1.31 million which beat the analyst consensus estimate of $1.06 million by 23.87 percent. This is a 769.54 percent increase over sales of $151.00 thousand the same period last year.
Plus Therapeutics（納斯達克股票代碼：PSTV）公佈的季度虧損爲每股0.70美元，比分析師普遍預期的1.07美元（1.07美元）高出34.58％。這比去年同期每股虧損2.40美元（2.40美元）增長了70.83％。該公司公佈的季度銷售額爲131萬美元，比分析師普遍預期的106萬美元高出23.87％。這比去年同期的15.1萬美元的銷售額增長了769.54％。